Literature DB >> 18031560

Migraine without aura: comparison with cervicogenic headache. Vågå study of headache epidemiology.

O Sjaastad1, L S Bakketeig.   

Abstract

OBJECTIVES: To study migraine without aura (MwoA) prevalence in the commune of Vågå, Norway; 1838 (18- to 65-year-old) individuals were included. A special search was made for cervicogenic characteristics in MwoA, as it has been claimed that such characteristics may frequently be present. A comparison with cervicogenic headache (CEH) was made.
METHODS: The MwoA and tension-type headache (T-TH) diagnosis was based on IHS criteria. CEH diagnosis was based on the principles of The Cervicogenic Headache International Study Group.
RESULTS: There were 562 cases of MwoA; prevalence: 31%. There were 425 cases of 'pure' MwoA, i.e. without coexisting T-TH. These 'pure' cases were used for extracting MwoA symptoms. The female/male ratio was 1.69, the corresponding ratio in CEH being 0.71. Typical MwoA symptoms such as nausea/photophobia were most frequently found in migraine. This difference amounted to a factor of > or =2.6. On the other hand, typical CEH traits, like mechanical pain provocation and 'posterior' onset of exacerbations, occurred more frequently in CEH than in MwoA. The difference amounted to a factor of two or more.
CONCLUSIONS: MwoA and CEH have clearly different characteristics. The differences between MwoA and CEH are staggering. It is unlikely that migraine and CEH are linked in a nosological sense.

Entities:  

Mesh:

Year:  2007        PMID: 18031560     DOI: 10.1111/j.1600-0404.2007.00966.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  10 in total

1.  Comparative analysis and diagnostic accuracy of the cervical flexion-rotation test.

Authors:  Toby M Hall; Kathy Briffa; Diana Hopper; Kim Robinson
Journal:  J Headache Pain       Date:  2010-05-28       Impact factor: 7.277

Review 2.  Cervicogenic headache: a review comparison with migraine, tension-type headache, and whiplash.

Authors:  Maurice B Vincent
Journal:  Curr Pain Headache Rep       Date:  2010-06

3.  Tension-type headache: one or more headaches?

Authors:  Ottar Sjaastad
Journal:  Funct Neurol       Date:  2011 Jul-Sep

4.  The importance of craniovertebral and cervicomedullary angles in cervicogenic headache.

Authors:  Gökçen Çoban; İlker Çöven; Bilal Egemen Çifçi; Erkan Yıldırım; Ayşe Canan Yazıcı; Bahriye Horasanlı
Journal:  Diagn Interv Radiol       Date:  2014 Mar-Apr       Impact factor: 2.630

5.  Dose response and efficacy of spinal manipulation for chronic cervicogenic headache: a pilot randomized controlled trial.

Authors:  Mitchell Haas; Adele Spegman; David Peterson; Mikel Aickin; Darcy Vavrek
Journal:  Spine J       Date:  2010-02       Impact factor: 4.166

Review 6.  Prevalence of headache in Europe: a review for the Eurolight project.

Authors:  Lars Jacob Stovner; Colette Andree
Journal:  J Headache Pain       Date:  2010-05-16       Impact factor: 7.277

7.  Clinical evaluation of cervicogenic headache: a clinical perspective.

Authors:  Toby Hall; Kathy Briffa; Diana Hopper
Journal:  J Man Manip Ther       Date:  2008

8.  Greater occipital nerve blocks in the treatment of refractory chronic migraine: An observational report of nine cases.

Authors:  Abdulkadir Koçer
Journal:  World J Clin Cases       Date:  2016-10-16       Impact factor: 1.337

9.  The epidemiology of headache disorders: a face-to-face interview of participants in HUNT4.

Authors:  Knut Hagen; Anders Nikolai Åsberg; Benjamin L Uhlig; Erling Tronvik; Eiliv Brenner; Marit Stjern; Grethe Helde; Gøril Bruvik Gravdahl; Trond Sand
Journal:  J Headache Pain       Date:  2018-03-20       Impact factor: 7.277

10.  Fluoroscopy-Guided Blockade of the Greater Occipital Nerve in Cadavers: A Comparison of Spread and Nerve Involvement for Different Injectate Volumes.

Authors:  Zhanfeng Song; Shuming Zhao; Jianqing Ma; Zhanyong Wu; Sidong Yang
Journal:  Pain Res Manag       Date:  2020-09-22       Impact factor: 3.037

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.